Healthcare
AMA Expresses Opposition to FDA Committee Recommendation on Compounded Peptides
The American Medical Association has formally advocated for rigorous regulatory oversight and safety testing regarding the compounding of synthetic peptide products. This follows a July 2026 vote by an FDA advisory committee to include certain peptides on a list of substances permitted for compounding, a decision that diverged from the recommendations of some agency scientists. The AMA continues to emphasize the necessity of evidence-based standards to ensure patient safety and efficacy in compounded medications.
"AMA Expresses Opposition to FDA Committee Recommendation on Compounded Peptides" — will this still be in the news a week from now?
"AMA Expresses Opposition to FDA Committee Recommendation on Compounded Peptides" — do you expect real action to follow, not just talk?
Sources
- The FDA's Dangerous New Compounding Policy — National Review
- AMA Challenges Federal Drug Compounding Rules — Politico
- Nov. 6, 2026: National Advocacy Update — American Medical Association
Topics
- Universe One
- Healthcare
- expresses
- opposition
- committee
- recommendation
- compounded
- peptides